IPHA Innate Pharma S.A.

NASDAQ
$1.50

Innate Pharma S.A. (IPHA) is confirmed to report earnings on November 5, 2026, before the market open.

Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Innate Pharma S.A.

Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.